Clinical Results On The Use Of Bacterin International, Inc.’S Osteosponge® For Foot And Ankle Arthrodeses Procedures Published In Orthopedics Today

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BELGRADE, Mont.--(BUSINESS WIRE)--Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft materials and bioactive coatings for medical applications, announces that results utilizing OsteoSponge® bone graft for foot and ankle arthrodeses procedures has been published in the peer-reviewed journal Orthopedics. This is the second publication for Bacterin that highlights clinical outcomes of OsteoSponge® for foot and ankle fusion procedures.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC